Full remission inside refractory intense lymphoblastic the leukemia disease utilizing blinatumomab right after failing associated with a reaction to CD-19 chimeric antigen receptor T-cell treatments.
https://www.selleckchem.com/products/SNS-032.html
Sex:
Female
relishicon40's Signature
(Hidden)relishicon40 Profil
Registration Date: 09-16-2023 Date of Birth: November 21 Yaşı: Status: ( @ )
